Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Raman spectroscopic monitoring of hemodialysis

a raman spectroscopy and hemodialysis technology, applied in the field of raman spectroscopy monitoring of hemodialysis, can solve the problems of urea buildup in the body and particularly in the blood, not allowing continuous evaluation of effectiveness, and requiring time-consuming chemical analyses, so as to reduce the time a patient has to spend, monitor and/or control hemodialysis

Inactive Publication Date: 2008-07-03
PRESCIENT MEDICAL
View PDF48 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides methods for continuously monitoring the levels of urea and other substances in the blood of patients undergoing hemodialysis. This is done using a special technique called spectroscopic analysis, specifically low resolution Raman spectroscopy. This allows for direct and continuous measurement of the urea levels while the patient is still attached to the dialysis equipment. The invention can also reduce the time a patient needs to spend undergoing hemodialysis. The system uses a laser light to make measurements and can identify and quantify the levels of urea and other substances in the blood."

Problems solved by technology

However, during kidney impairment or failure, urea builds up in the body and particularly in the blood.
However, both the URR and Kt / V techniques currently employed assessments of hemodialysis efficiency of treatment are point measurements, often not even performed at every dialysis treatment, that do not allow continuous evaluation of effectiveness.
Both require blood sampling before and after treatment and require time consuming chemical analyses.
As a consequence, the measurements cannot be used to determine actual urea clearance efficiency or control the extent and duration of an individual patient's dialysis session.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Raman spectroscopic monitoring of hemodialysis
  • Raman spectroscopic monitoring of hemodialysis
  • Raman spectroscopic monitoring of hemodialysis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020]Without being bound by any particular embodiment, the following discussion is offered to facilitate understanding of the invention. The present invention provides methods for monitoring levels of at least one analyte in blood of a patient undergoing hemodialysis using Raman spectroscopy, taking advantage of the optical access afforded through the clear delivery tubing connecting the patient's blood flow to the dialyzer. Unique Raman spectroscopic signature of an analyte can be identified and quantified against a whole blood background utilizing the Raman spectroscopy-based systems.

[0021]The analytes of particular interest in the present invention are the products of metabolic activity within the body of the patient. The term “analyte” as employed herein, however, can encompass any chemical composition released in the bloodstream (e.g., toxins released by microorganisms or a compound imbibed by an individual). The analyte contained in the blood may be a specific analyte or a co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
excitation wavelengthsaaaaaaaaaa
poweraaaaaaaaaa
diametersaaaaaaaaaa
Login to View More

Abstract

Spectroscopic systems and methods are disclosed for determining levels of at least one analyte in blood undergoing hemodialysis. In one aspect, the invention employs Raman spectroscopy to monitor and / or control hemodialysis. In one embodiment, the system uses a laser light directed to circulating blood from a patient undergoing dialysis to make Raman spectral measurements. For example, the laser light can be directed into a segment of the dialysis tubing. The system can utilize unique Raman spectroscopic signature of one or more analytes, e.g., urea, to identify and quantify such analytes against a whole blood background. Based on the spectral response, the concentration of the analytes can be monitored and / or used to control hemodialysis.

Description

FIELD OF THE INVENTION[0001]The technical field of this invention relates to methods for monitoring analyte levels in blood by Raman spectroscopy systems. More particularly, it relates to methods for monitoring urea levels in blood while a patient is undergoing hemodialysis by using Raman spectroscopy systems.BACKGROUND OF THE INVENTION[0002]When protein is broken down in the body, urea is produced as one of the waste products. Normally, urea is removed from the body by the kidneys and excreted as urine. However, during kidney impairment or failure, urea builds up in the body and particularly in the blood.[0003]When kidneys fail, dialysis is necessary to remove waste products such as urea from the blood. Urea is not very toxic by itself, but its level represents the levels of many other waste products that build up in the blood when the kidneys fail. The need for a patient to undergo dialysis particularly becomes acute in end stage renal disease (ESRD). ERSD causes people to experie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N33/48A61B5/00A61M1/14A61M1/36G01N21/65
CPCA61B5/0059A61B5/14546A61M1/14A61M1/367A61M2230/20Y10T436/173845G01N2021/651A61M1/3609Y10T436/17Y10T436/171538G01N21/65
Inventor WOMBLE, M. EDWARDCLARKE, RICHARD H.
Owner PRESCIENT MEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products